Experienced in Hypothalamic Hamartomas

Dr. Prakash Ambady

Neurology
Providence
9135 Southwest Barnes Road, Suite 461, 
Portland, OR 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Hypothalamic Hamartomas
Providence
9135 Southwest Barnes Road, Suite 461, 
Portland, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Prakash Ambady is a Neurologist in Portland, Oregon. Dr. Ambady is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Ambady is currently accepting new patients.

His clinical research consists of co-authoring 42 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in OR
Hospital Affiliations
Ohsu Hospital And Clinics
Providence Portland Medical Center
Providence St Vincent Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
ATRIO Health
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Prominence Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

9135 Southwest Barnes Road, Suite 461, Portland, OR 97225
Call: 503-216-1150

Additional Areas of Focus

Dr. Ambady has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS
The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS
Enrollment Status: Recruiting
Publish Date: February 28, 2025
Intervention Type: Procedure, Drug
Study Phase: Phase 2
Response Assessment to Pembrolizumab With Standard of Care Therapy in Glioblastoma Using Ferumoxytol Steady State Imaging- A Pilot Study
Response Assessment to Pembrolizumab With Standard of Care Therapy in Glioblastoma Using Ferumoxytol Steady State Imaging- A Pilot Study
Enrollment Status: Terminated
Publish Date: September 09, 2025
Intervention Type: Drug, Procedure, Other, Biological
Study Drugs: Ferumoxytol, Pembrolizumab
Study Phase: Phase 2
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients With Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) That Are Causing Significant Morbidity
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2025
Intervention Type: Drug
Study Drug: Mirdametinib
Study Phase: Phase 2
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: June 05, 2025
Intervention Type: Biological
Study Drugs: PVSRIPO, Pembrolizumab
Study Phase: Phase 2
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
The Use of Perfusion MRI Using Ferumoxytol and Small Molecular Weight Gadolinium (Gd) Agents to Assess Response to Pembrolizumab in Brain Metastases and Systemic Lesions in NSCLC: A Comparison of Imaging Modalities to Address Brain Metastases, Pseudoprogression, and Systemic Lesion Tumor Flare (Neuro-Check Pilot)
The Use of Perfusion MRI Using Ferumoxytol and Small Molecular Weight Gadolinium (Gd) Agents to Assess Response to Pembrolizumab in Brain Metastases and Systemic Lesions in NSCLC: A Comparison of Imaging Modalities to Address Brain Metastases, Pseudoprogression, and Systemic Lesion Tumor Flare (Neuro-Check Pilot)
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Procedure, Drug, Other, Biological
Study Drug: Ferumoxytol
Study Phase: Phase 2
View 5 Less Clinical Trials

41 Total Publications

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 08, 2024
View All 41 Publications
Similar Doctors
Experienced in Hypothalamic Hamartomas
Dr. Aaron B. Lyles
Neurology | Physiatry
Experienced in Hypothalamic Hamartomas
Dr. Aaron B. Lyles
Neurology | Physiatry
4805 Northeast Glisan Street, Floor 4, 
Portland, OR 
 (7.8 miles away)
503-215-5710
Languages Spoken:
English
See accepted insurances

Aaron Lyles is a Physiatrist and a Neurologist in Portland, Oregon. Dr. Lyles is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Stroke, Post Polio Syndrome, Hemiplegia, and Tieche-Jadassohn Nevus.

VIEW MORE HYPOTHALAMIC HAMARTOMAS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ambady's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Ambady is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Brain Tumor
    Dr. Ambady is
    Elite
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Glioblastoma
    Dr. Ambady is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Glioma
    Dr. Ambady is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Gliomatosis Cerebri
    Dr. Ambady is
    Elite
    . Learn about Gliomatosis Cerebri.
    See more Gliomatosis Cerebri experts
  • Distinguished
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Ambady is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Ambady is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Ependymoma
    Dr. Ambady is
    Distinguished
    . Learn about Ependymoma.
    See more Ependymoma experts
  • Gliosarcoma
    Dr. Ambady is
    Distinguished
    . Learn about Gliosarcoma.
    See more Gliosarcoma experts
  • Metastatic Brain Tumor
    Dr. Ambady is
    Distinguished
    . Learn about Metastatic Brain Tumor.
    See more Metastatic Brain Tumor experts
  • Neuroepithelioma
    Dr. Ambady is
    Distinguished
    . Learn about Neuroepithelioma.
    See more Neuroepithelioma experts
View All 11 Distinguished Conditions
  • Advanced
  • Brain Stem Cancer
    Dr. Ambady is
    Advanced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Choroid Plexus Papilloma
    Dr. Ambady is
    Advanced
    . Learn about Choroid Plexus Papilloma.
    See more Choroid Plexus Papilloma experts
  • Diffuse Midline Glioma H3 K27M-Mutant
    Dr. Ambady is
    Advanced
    . Learn about Diffuse Midline Glioma H3 K27M-Mutant.
    See more Diffuse Midline Glioma H3 K27M-Mutant experts
  • Medulloblastoma
    Dr. Ambady is
    Advanced
    . Learn about Medulloblastoma.
    See more Medulloblastoma experts
  • Neurofibromatosis
    Dr. Ambady is
    Advanced
    . Learn about Neurofibromatosis.
    See more Neurofibromatosis experts
  • Neurofibromatosis Type 2 (NF2)
    Dr. Ambady is
    Advanced
    . Learn about Neurofibromatosis Type 2 (NF2).
    See more Neurofibromatosis Type 2 (NF2) experts
View All 7 Advanced Conditions
  • Experienced
  • Cerebral Ventricle Cancer
    Dr. Ambady is
    Experienced
    . Learn about Cerebral Ventricle Cancer.
    See more Cerebral Ventricle Cancer experts
  • Complex Regional Pain Syndrome
    Dr. Ambady is
    Experienced
    . Learn about Complex Regional Pain Syndrome.
    See more Complex Regional Pain Syndrome experts
  • Cowden Syndrome
    Dr. Ambady is
    Experienced
    . Learn about Cowden Syndrome.
    See more Cowden Syndrome experts
  • Dysembryoplastic Neuroepithelial Tumors (DNET)
    Dr. Ambady is
    Experienced
    . Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).
    See more Dysembryoplastic Neuroepithelial Tumors (DNET) experts
  • Hypothalamic Hamartomas
    Dr. Ambady is
    Experienced
    . Learn about Hypothalamic Hamartomas.
    See more Hypothalamic Hamartomas experts
  • Legius Syndrome
    Dr. Ambady is
    Experienced
    . Learn about Legius Syndrome.
    See more Legius Syndrome experts
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.